AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 171 filers reported holding AVANIR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $27,000 | -99.4% | 1,607 | -99.6% | 0.00% | -100.0% |
Q3 2014 | $4,734,000 | +268.4% | 397,125 | +13.4% | 0.07% | +231.8% |
Q1 2014 | $1,285,000 | -20.6% | 350,066 | -27.3% | 0.02% | -8.3% |
Q4 2013 | $1,619,000 | +102.4% | 481,842 | +155.5% | 0.02% | +60.0% |
Q3 2013 | $800,000 | +144.6% | 188,597 | +164.9% | 0.02% | +87.5% |
Q2 2013 | $327,000 | – | 71,190 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JAY JEFFREY R | 258,600 | $1,190,000 | 0.94% |
BVF INC/IL | 1,006,053 | $4,628,000 | 0.90% |
Artal Group S.A. | 2,750,000 | $12,650,000 | 0.40% |
Baker Brothers Advisors | 3,578,591 | $16,462,000 | 0.33% |
EAM Investors, LLC | 237,017 | $1,090,000 | 0.24% |
Opus Trading Fund LLC | 23,888 | $110,000 | 0.21% |
FORTALEZA ASSET MANAGEMENT INC/ | 61,795 | $284,000 | 0.16% |
CR Intrinsic Investors, LLC | 898,538 | $4,133,000 | 0.14% |
TimesSquare Capital Management, LLC | 4,261,478 | $19,603,000 | 0.12% |
Lyons Wealth Management, LLC. | 25,340 | $116,000 | 0.12% |